Read all the latest news articles from the Royal Society of Tropical Medicine and Hygiene
We’ve invited our Country Ambassadors to reflect on their country’s COVID-19 response. Let’s hear from Ivan Nkaiwa, our Country Ambassador for Botswana.
We’ve invited our Country Ambassadors to reflect on their country’s COVID-19 response. Let’s hear from Professor John Aaskov, our Country Ambassador for Australia.
This year we have once again seen a record number of applicants for our small grants programme, receiving 932 applications in total.
We have a week to go for RSTMH small grant submissions and we would love to see more applications from those early in their careers, from around the world.
The World Health Organization (WHO) has issued interim guidance for NTD programmes in accordance with the public health measures put in place to curb the Covid-19 pandemic.
As we enter the third month of COVID-19, I wanted to share a few personal reflections.
Response from our members and Fellows what they felt RSTMH should be doing to help the global efforts to tackle COVID-19.
Soulsby Foundation has opened a call for applications for the 2020 Travelling Fellowships Programme
Dr Caroline Harper, the Chief Executive of UK-based NGO Sightsavers, has been selected by RSTMH and LSTM as the winner of the first Hemingway Award.
The ASCEND (Accelerating Sustainable Control and Elimination of Neglected Tropical Diseases) programme is a £200m investment to advance the impact and sustainability of national programmes tackling NTDs.
RSTMH delivered the five-day event under the theme “25 years: investigation, innovation and implementation”.
We believe that in our ever more interconnected world, we must consider human health alongside animal health and the environment.
With over 120 small grants funded in 2020, hlet's take a look at the amazing projects being undertaken by our awardees.
The title “Neglected Tropical Diseases of the Skin or Skin NTDs” is a recent designation that encompasses a group of NTDs that share a common feature, namely that they present with lesions on the surface of the body.
Evidence suggests that microbial infections are associated with the production of specific volatile organic compounds (VOCs), causing the release of distinct odours. This area of research has led to interest in using volatiles as biomarkers of infectious diseases, such as cholera, malaria and now COVID-19.